Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
Effect of light finger touch in balance control of individuals with multiple sclerosis.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
Impaired functional integration in multiple sclerosis: a graph theory study.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Acute disseminated encephalomyelitis: current knowledge and open questions.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Long-term safety of azathioprine therapy in multiple sclerosis.
[Oral treatments in multiple sclerosis].
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.
[Experience in the use of high-frequency selective percutaneous rhizotomy in trigeminal neuralgia associated with multiple sclerosis].
Frequent laboratory abnormalities in CIDP patients.
Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]

Pages